Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-24 @ 10:55 PM
NCT ID:
NCT02809469
Eligibility Criteria:
Inclusion Criteria:
* Patients with non-valvular atrial fibrillation (permanent, paroxysmal, or persistent) receiving apixaban with any of the following characteristics: age\>85; creatinine clearance \<40mL/min; or body weight \<50kg.
Exclusion Criteria:
* Inability to visit Hamilton General Hospital;
* Inability or unwillingness to provide written informed consent.
* Stroke or thromboembolic event in the past 6 months.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02809469
Study Brief:
Protocol Section:
NCT02809469